Results 181 to 190 of about 13,052,428 (347)

Inspecting subjects and aspects 11 - 18 : Art [PDF]

, 1999

core  

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1617, a Cathepsin-S Inhibitor, in Healthy Adult Subjects. [PDF]

Clin Transl Sci
Kojima T, Chen W, Smulders R, Stanhope S, Kowalski D, Heo N, Moy S, Goldston A, Han D, Zhu T.   +9 more
europepmc   +1 more source

Inspecting subjects and aspects 11 - 18 : Music [PDF]

, 1999

core  

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

TMPRSS6 Non-Coding Variants in the Expression of Iron Refractory Iron Deficiency Anemia in Monoallelic Subjects. [PDF]

Genes (Basel)
Hoving V, Donker AE, Smeets RJP, van den Heuvel BPWJ, Schols SEM, Swinkels DW.   +5 more
europepmc   +1 more source

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.

New England Journal of Medicine, 2006
R. Belfort, S. Harrison, K. A. Brown, Celia Darland, J. Finch, Jean Hardies, B. Balas, A. Gastaldelli, F. Tio, Joseph P Pulcini, R. Berria, Jennie Z. Ma, S. Dwivedi, R. Havranek, C. Fincke, R. DeFronzo, G. Bannayan, S. Schenker, K. Cusi   +18 more
semanticscholar   +1 more source

Inspecting subjects and aspects 11 - 18 : Geography [PDF]

, 1999

core  

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Replication and validation of two novel magnetoencephalography functional connectivity measures in Alzheimer's disease. [PDF]

Imaging Neurosci (Camb)
Scheijbeler EP, Molleson M, Schoonhoven DN, van Nifterick AM, Hillebrand A, de Haan W, Stam CJ, Gouw AA.   +7 more
europepmc   +1 more source